Sort
51,593 grants matching “hepatitis”
TNF and Mitochondrial Dysfunction in ALD
$380,589Craig J McClain · University Of Louisville · R37 · FY2010 · AA
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$380,547Douglas K Owens · Stanford University · R37 · FY2020 · DA
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
$380,536Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2008 · DA
RNA-binding proteins in atherosclerosis
$380,529Tamer Sallam · University Of California Los Angeles · R01 · FY2021 · HL
DIABETES PREVENTION PROGRAM (DPP)
$380,526Yeshiva University · U01 · FY2002 · DK
RNA m6A methylation contributes to hepatic inflammation in obesity-associated NAFLD
$380,495Xinshou Ouyang · Yale University · R01 · FY2024 · DK
NIDA Clinical Trials Network: Greater New York Node
$380,441John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Omics Core
$380,400Xiang Zhang · University Of Louisville · P50 · FY2023 · AA
Mechanisms of alcohol and menthol dependent pharmaco-neurological interactions with arecoline, an addictive and toxic areca (betel) nut xenobiotic
$380,397Alan L Myers · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · DA
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
$380,395Patrick Viatour · Lankenau Institute For Medical Research · R01 · FY2025 · CA
Adult to adult living donor liver transplantation cohor*
$380,389Gregory Thomas Everson · University Of Colorado Denver · U01 · FY2008 · DK
Brief Alcohol Intervention for HIV-infecetd MSM in Primary Care Setting
$380,355Christopher W. Kahler · Brown University · P01 · FY2013 · AA
AAV2-F.IX Hepatic Gene Transfer under Immunomodulation
$380,350Valder R Arruda · Children'S Hosp Of Philadelphia · R01 · FY2006 · HL
Mechanisms of Hepadnavirus Assembly and Replication
$380,343Jianming Hu · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2016 · AI
RNA-binding proteins in atherosclerosis
$380,340Tamer Sallam · University Of California Los Angeles · R01 · FY2022 · HL
Isolation of antiviral proteins from natural product extracts.
$380,339Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
$380,328Michael E Jung · University Of California Los Angeles · R01 · FY2023 · AI
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
$380,328Michael E Jung · University Of California Los Angeles · R01 · FY2025 · AI
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
$380,328Genhong Cheng · University Of California Los Angeles · R01 · FY2020 · AI
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
$380,328Genhong Cheng · University Of California Los Angeles · R01 · FY2021 · AI
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
$380,328Genhong Cheng · University Of California Los Angeles · R01 · FY2022 · AI
Mechanism of autoimmune hepatitis development in a novel mouse model
$380,281Konstantina Alexandropoulos · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · DK
Mechanism of autoimmune hepatitis development in a novel mouse model
$380,281Konstantina Alexandropoulos · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK
Mechanism of autoimmune hepatitis development in a novel mouse model
$380,281Konstantina Alexandropoulos · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DK
Mechanism of autoimmune hepatitis development in a novel mouse model
$380,281Konstantina Alexandropoulos · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DK